A pregnant patient with a history of opioid use disorder is admitted with signs of possible preeclampsia, including elevated blood pressure, right upper quadrant pain, and elevated liver enzymes. What is the nurse's priority intervention to address the patient's condition?

A) Administer antihypertensive medication as prescribed and monitor blood pressure closely.

B) Initiate IV fluid therapy to address dehydration and ketonuria.

C) Provide nutritional counseling to improve dietary intake.

D) Prepare the patient for immediate delivery to prevent fetal distress.

A pregnant patient with a history of opioid use disorder and elevated blood pressure is admitted for suspected preeclampsia. Her laboratory results reveal elevated liver enzymes and mild creatinine elevation. What is the priority nursing intervention to address both maternal and fetal well-being in this scenario?

B) Begin a magnesium sulfate infusion to prevent seizures and assess fetal heart rate variability.

A) Administer methyldopa to lower blood pressure and monitor fetal heart rate continuously.

B) Begin a magnesium sulfate infusion to prevent seizures and assess fetal heart rate variability.

C) Encourage oral fluid intake to improve hydration and manage mild renal impairment.

D) Increase caloric intake to address ketonuria and provide fetal monitoring every 4 hours.

A patient with preeclampsia and opioid use disorder is being managed in the hospital. She presents with elevated blood pressure, proteinuria, and worsening liver enzyme levels. Continuous fetal monitoring reveals intermittent late decelerations. What is the nurse's priority action for this patient?

A) Administer magnesium sulfate as ordered to prevent seizures.

B) Increase the rate of IV fluids to improve renal perfusion.

C) Prepare the patient for an immediate cesarean delivery.

D) Re-position the patient to her left side to improve uteroplacental blood flow.

A patient with preeclampsia and opioid use disorder is being treated with intravenous labetalol to manage hypertension and intravenous fluids to address dehydration. Despite these interventions, the patient’s blood pressure remains elevated and liver enzymes are increasing. Continuous fetal monitoring shows intermittent late decelerations. What is the priority nursing intervention to address the current situation?

C) Administer magnesium sulfate to prevent seizures.

A) Continue monitoring fetal heart rate and prepare for potential delivery.

B) Increase the rate of intravenous fluids to improve renal perfusion.

C) Administer magnesium sulfate to prevent seizures.

D) Request an immediate increase in labetalol dosage to control blood pressure.

A 32-year-old pregnant patient with a history of opioid use disorder is undergoing an expedited cesarean section due to severe preeclampsia and fetal distress. During the procedure, the anesthesiologist decides to use a regional anesthesia technique to minimize opioid exposure. Which of the following interventions is most important for the nurse to implement postoperatively to manage the patient's pain effectively while addressing her opioid use disorder?

A) Administer scheduled doses of acetaminophen and ibuprofen, and utilize non-pharmacological pain management techniques.

B) Administer intravenous morphine as needed for severe pain, while closely monitoring for signs of opioid dependence.

C) Educate the patient on the use of patient-controlled analgesia (PCA) with fentanyl for breakthrough pain management.

D) Coordinate with the pain management team for the introduction of a transdermal buprenorphine patch post-surgery.

A pregnant patient with opioid use disorder presents with severe hypertension, right upper quadrant pain, and brisk deep tendon reflexes. The healthcare team has initiated magnesium sulfate therapy. What is the primary nursing intervention to monitor for magnesium sulfate toxicity in this patient?

B) Assess deep tendon reflexes hourly

A) Monitor blood pressure every 15 minutes

B) Assess deep tendon reflexes hourly

C) Check serum magnesium levels every 4 hours

D) Measure urine output every 8 hours

A postpartum patient who underwent a cesarean section is showing signs of HELLP syndrome, with elevated liver enzymes and a low platelet count. She is also experiencing confusion, brisk deep tendon reflexes, and right upper quadrant pain. What is the priority nursing intervention to address her current condition?

B) Continue magnesium sulfate infusion and monitor neurological status closely.

A) Administer an antihypertensive medication to manage her blood pressure.

B) Continue magnesium sulfate infusion and monitor neurological status closely.

C) Prepare the patient for an emergency CT scan to assess for intracranial bleeding.

D) Educate the patient about the signs and symptoms of neonatal abstinence syndrome.

A postpartum patient who underwent an expedited cesarean section is now showing signs of progression towards HELLP syndrome. Considering her current condition, what would be the most appropriate nursing intervention to prioritize?

C) Monitor neurological status closely and prepare for potential seizure activity.

A) Encourage early ambulation to prevent deep vein thrombosis.

B) Administer antihypertensive medication to maintain blood pressure control.

C) Monitor neurological status closely and prepare for potential seizure activity.

D) Provide dietary modifications to support liver function recovery.

A patient with suspected HELLP syndrome is exhibiting increased confusion and disorientation, and her blood pressure is fluctuating. Which of the following nursing interventions is the highest priority?

C) Prepare for potential seizure precautions and administer magnesium sulfate as ordered.

A) Monitor the patient's neurological status every 4 hours.

B) Administer labetalol as prescribed to stabilize blood pressure.

C) Prepare for potential seizure precautions and administer magnesium sulfate as ordered.

D) Initiate corticosteroid therapy to improve platelet counts.

A patient diagnosed with HELLP syndrome is experiencing elevated liver enzymes and decreasing platelet count. Which nursing intervention should be prioritized to address the potential complications associated with this condition?

C) Prepare the patient for possible early delivery to prevent further maternal complications

A) Administer corticosteroids as prescribed to improve platelet counts

B) Monitor for signs of infection and initiate antibiotics

C) Prepare the patient for possible early delivery to prevent further maternal complications

D) Educate the patient on dietary modifications to support liver function

opioid addiction in pregnancy - Nursing Case Study

Pathophysiology

• Primary mechanism: Opioids bind to mu-opioid receptors in the brain, altering pain perception and triggering the release of dopamine, which reinforces drug-taking behavior and leads to addiction.

• Secondary mechanism: Chronic opioid use disrupts the hypothalamic-pituitary-adrenal (HPA) axis, leading to hormonal imbalances that can affect both maternal health and fetal development, increasing the risk of withdrawal symptoms in newborns.

• Key complication: Opioid addiction during pregnancy can result in neonatal abstinence syndrome (NAS), where the newborn experiences withdrawal symptoms post-delivery, requiring specialized care and monitoring.

Patient Profile

Demographics:

28-year-old female, retail manager

History:

• Key past medical history: History of opioid use disorder, depression, and two prior pregnancies without complications

• Current medications: Prenatal vitamins, buprenorphine-naloxone (Suboxone), sertraline

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increased fatigue and abdominal pain

• Key symptoms: Nausea, vomiting, decreased fetal movement, and occasional shortness of breath

• Vital signs: Blood pressure 140/90 mmHg, heart rate 105 bpm, respiratory rate 22 breaths per minute, temperature 98.6°F

Section 1

During the initial assessment, the healthcare team observes that the patient's blood pressure has remained elevated at 142/92 mmHg, and her heart rate continues at a tachycardic level of 110 bpm. The fetal heart rate monitor shows a baseline of 170 bpm, raising concerns about possible fetal distress. The patient's abdominal pain is located in the right upper quadrant, and she rates it as a 6 out of 10 on the pain scale. The nausea and vomiting have persisted, and the patient reports that she has been unable to keep much food or fluid down over the past 24 hours. Her physical exam reveals mild edema in the lower extremities.

Laboratory results indicate elevated liver enzymes with an AST of 95 U/L and ALT of 112 U/L, suggesting possible liver dysfunction. There is also a mild elevation in creatinine at 1.2 mg/dL, which may indicate developing renal impairment. The patient's urine drug screen is negative for opioids, consistent with her reported adherence to buprenorphine-naloxone therapy, but shows signs of ketonuria, possibly due to poor nutritional intake and dehydration. These findings, coupled with her symptoms, suggest the possibility of preeclampsia, superimposed on her opioid use disorder.

Given these developments, the healthcare team plans to admit the patient for close monitoring and further evaluation. The priority is to stabilize her blood pressure and assess fetal well-being through continuous monitoring. The potential for preeclampsia, combined with her history of opioid use disorder, necessitates a multidisciplinary approach to manage both maternal and fetal health. The focus will be on optimizing maternal stability while minimizing the risk of neonatal abstinence syndrome and ensuring appropriate neonatal care post-delivery.

Section 2

As the patient settles into the hospital setting, the healthcare team initiates a regimen to stabilize her blood pressure and manage her symptoms. Intravenous labetalol is administered to control her hypertension, and IV fluids are started to address dehydration and improve renal perfusion. Continuous fetal monitoring reveals intermittent late decelerations, raising concerns about sustained fetal distress. The obstetrics team recommends a biophysical profile (BPP) to further assess fetal well-being, alongside Doppler studies to evaluate uteroplacental blood flow.

New diagnostic results return, showing further elevation of liver enzymes, with AST rising to 120 U/L and ALT to 145 U/L. These findings, coupled with the patient's persistent right upper quadrant pain, suggest worsening liver involvement. Urinalysis confirms significant proteinuria, supporting the diagnosis of preeclampsia. Repeat blood pressure readings remain elevated at 144/94 mmHg, despite initial interventions, necessitating the consideration of magnesium sulfate for seizure prophylaxis. The patient’s creatinine has slightly increased to 1.4 mg/dL, indicating ongoing renal strain.

In response to these developments, the team faces the challenge of managing the dual complications of preeclampsia and opioid use disorder. The priority is to maintain maternal stability while preparing for a potential preterm delivery if fetal distress persists. The multidisciplinary team, including obstetrics, anesthesia, and pediatrics, prepares to address the risk of neonatal abstinence syndrome post-delivery, emphasizing the need for coordinated care. The patient is closely monitored for any neurological changes, given the risk of eclampsia, and discussions about potential delivery options are initiated, balancing maternal and fetal risks.

Section 3

As the clinical team continues to monitor the patient, they observe a significant change in her status. Over the next few hours, her blood pressure spikes, reaching 160/105 mmHg, despite the ongoing administration of intravenous labetalol. The patient's right upper quadrant pain intensifies, accompanied by increasing nausea and a new onset of mild confusion, prompting immediate concern for potential eclampsia. Neurological assessment reveals brisk deep tendon reflexes, raising the suspicion of worsening central nervous system involvement. Given these alarming changes, the healthcare team urgently administers magnesium sulfate to prevent seizures and orders a stat CT scan of the head to rule out intracranial complications.

The results of the biophysical profile reveal a score of 4/10, indicating significant fetal compromise, with abnormalities in fetal tone and movements, as well as a concerning decrease in amniotic fluid volume. Doppler studies further confirm reduced uteroplacental blood flow, heightening the urgency of the situation. The obstetrics and neonatology teams convene to discuss the risks and benefits of immediate delivery versus continued in-utero monitoring, considering the potential for both maternal and fetal deterioration.

In light of these developments, the decision is made to proceed with an expedited cesarean section. The team prepares for the complexities associated with the patient's opioid use disorder, anticipating the need for enhanced pain management strategies and careful monitoring postoperatively. Anesthesia consults on the best approach to minimize opioid use while ensuring adequate analgesia. The neonatology team stands ready to manage potential neonatal abstinence syndrome, with protocols in place to support the newborn's transition. This decision underscores the critical balance between maternal stabilization and fetal well-being, as both teams work together to optimize outcomes for mother and baby.

Section 4

Following the expedited cesarean section, the patient is transferred to the recovery unit where the clinical team closely monitors her vital signs and neurological status. Initially, her blood pressure shows a slight improvement, stabilizing at 150/95 mmHg, but she remains at risk for further hypertensive episodes. Despite the administration of magnesium sulfate, the patient's confusion persists, warranting continued neurological assessments. Her deep tendon reflexes remain brisk, and she reports persistent right upper quadrant pain, raising concerns about ongoing hepatic involvement.

Laboratory results return, revealing elevated liver enzymes with an ALT of 135 U/L and AST of 160 U/L, alongside a platelet count of 95,000/mm³. These findings suggest a progression towards HELLP syndrome, complicating her postpartum recovery. Her white blood cell count is slightly elevated at 13,500/mm³, which could indicate a stress response or an emerging infection. The healthcare team considers these results in conjunction with her ongoing symptoms to refine her treatment plan, emphasizing the need for vigilant monitoring and potential adjustments in her medication regimen.

The neonate, meanwhile, is in the neonatal intensive care unit, demonstrating signs of neonatal abstinence syndrome with mild irritability and difficulty feeding. The neonatology team initiates a protocol for supportive care, including swaddling and minimizing environmental stimuli, while assessing the need for pharmacological intervention. The mother is counseled on the expected course of neonatal abstinence syndrome and the importance of consistent care to support the infant's adaptation. As both mother and child face their respective challenges, the healthcare team continues to prioritize a coordinated approach, ensuring that each complication is addressed with informed clinical reasoning and collaborative care strategies.

Section 5

As the recovery period progresses, the patient's condition takes a concerning turn with the emergence of new complications. Her blood pressure, which had initially stabilized, begins to fluctuate, occasionally spiking to 160/100 mmHg. This variation necessitates adjustments in her antihypertensive regimen, with the healthcare team opting to introduce labetalol in combination with magnesium sulfate. Despite these efforts, the patient's neurological status deteriorates further; she now exhibits increased confusion and disorientation, raising the suspicion of a possible progression to eclampsia. A neurological consultation is requested, and the team remains vigilant for any seizure activity.

In addition to her neurological changes, the patient's laboratory results reveal worsening hepatic function. Her liver enzymes continue to trend upwards with an ALT of 165 U/L and AST of 190 U/L. The platelet count has decreased further to 85,000/mm³, heightening the concern for significant hepatic involvement and confirming the diagnosis of HELLP syndrome. Given these developments, the healthcare team deliberates the need for more aggressive interventions, including potential corticosteroid therapy to stabilize her condition and improve platelet counts. Concurrently, they initiate a thorough infectious workup due to the elevated white blood cell count, considering the differential diagnosis of an underlying infection as a contributing factor to her deteriorating status.

The neonate, meanwhile, shows signs of slight improvement with supportive care measures in the NICU. The irritability has decreased, and feeding patterns are gradually becoming more consistent. The neonatology team continues to monitor the infant closely, ready to initiate pharmacological treatment if necessary. The mother is informed about these updates and is encouraged to participate in kangaroo care to promote bonding and support her infant's recovery. The healthcare team remains focused on delivering integrated care for both mother and child, adjusting their strategies as new information arises and prioritizing interventions that address the multifaceted nature of their conditions.